Ocular Immunology and Inflammation: Vol 31, No 6

Por um escritor misterioso

Descrição

Ocular Immunology and Inflammation: Vol 31, No 6
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis - ScienceDirect
Ocular Immunology and Inflammation: Vol 31, No 6
IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation - Mucosal Immunology
Ocular Immunology and Inflammation: Vol 31, No 6
The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy
Ocular Immunology and Inflammation: Vol 31, No 6
Biomolecules, Free Full-Text
Ocular Immunology and Inflammation: Vol 31, No 6
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina: Molecular Therapy - Methods & Clinical Development
Ocular Immunology and Inflammation: Vol 31, No 6
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous
Ocular Immunology and Inflammation: Vol 31, No 6
Fellowship in Vitreoretinal Diseases and Surgery Department of Ophthalmology and Visual Sciences
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization
Ocular Immunology and Inflammation: Vol 31, No 6
IJMS, Free Full-Text
Ocular Immunology and Inflammation: Vol 31, No 6
Immune Retinal Vascular Disease - Virginia Calder, John Greenwood, Hamish Towler, Susan Lightman, 1995
de por adulto (o preço varia de acordo com o tamanho do grupo)